ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för rubitecan. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2015-05-21

Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.

Chen J, Lu S, Gu W, Peng P, Dong J, Xu F, Yang X, Xiong Z, Yang X.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2015.05.047

Bibliografisk träff 2015-03-01

Encapsulation in PLGA-PEG enhances 9- nitro-camptothecin cytotoxicity to human ovarian carcinoma cell line through apoptosis pathway.

Ahmadi F, Derakhshandeh K, Jalalizadeh A, Mostafaie A, Hosseinzadeh L.

Res Pharm Sci · research-article; journal article

Bibliografisk träff 2014-10-29

Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.

Lian X, Dong J, Zhang J, Teng Y, Lin Q, Fu Y, Gong T.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2014.10.055

Bibliografisk träff 2014-02-17

Synergism of cyclin-dependent kinase inhibitors with camptothecin derivatives in small cell lung cancer cell lines.

Hamilton G, Klameth L, Rath B, Thalhammer T.

Molecules · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/molecules19022077

Bibliografisk träff 2013-08-11

Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.

Chen J, Hu RR, Yang XX, Gu W, Tian R, Gong F, Luo L, Fang F, Chen ZP, Cai BC.

Cancer Chemother Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00280-013-2259-x

Bibliografisk träff 2013-07-19

Physicochemical characterization, solubilization, and stabilization of 9-nitrocamptothecin using pluronic block copolymers.

Saha SC, Patel D, Rahman S, Savva M.

J Pharm Sci · journal article · DOI 10.1002/jps.23671

Bibliografisk träff 2011-06-09

Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.

Zheng S, Chang S, Lu J, Chen Z, Xie L, Nie Y, He B, Zou S, Gu Z.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0021064

Bibliografisk träff 2010-12-30

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.

Yan Z, Zhu Z, Li K, Chen P, Wang L, Huang C, Xue J, Liu M.

Cancer Chemother Pharmacol · clinical trial, phase i; journal article · DOI 10.1007/s00280-010-1546-z

Bibliografisk träff 2006-01-01

Rubitecan.

Clark JW.

Expert Opin Investig Drugs · review; journal article · DOI 10.1517/13543784.15.1.71

Bibliografisk träff 2004-08-01

Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors.

de Jonge MJ, Droz JP, Paz-Ares L, van Oosterom AT, de Wit R, Chollet P, Baron B, Lacombe D, Mettinger K, Fumoleau P, EORTC-New Drug Development Group/New Drug Development Program.

Invest New Drugs · clinical trial, phase ii; clinical trial; journal article · DOI 10.1023/b:drug.0000026260.24275.02

Bibliografisk träff 2004-01-01

Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.

Författaruppgift saknas

Drugs R D · journal article · DOI 10.2165/00126839-200405050-00007

Bibliografisk träff 2002-02-01

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.

Ellerhorst JA, Bedikian AY, Smith TM, Papadopoulos NE, Plager C, Eton O.

Anticancer Drugs · clinical trial, phase ii; clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1097/00001813-200202000-00009

Bibliografisk träff 1999-05-01

A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer.

Stehlin JS, Giovanella BC, Natelson EA, De Ipolyi PD, Coil D, Davis B, Wolk D, Wallace P, Trojacek A.

Int J Oncol · comparative study; clinical trial; research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.3892/ijo.14.5.821